Efflux of tenofovir by the multidirug resistance-associated protein 4 (MRP4) is not affected by HIV protease inhibitors

被引：0
|
作者：
Ray, AS [1 ]
Vela, JE [1 ]
Robinson, KL [1 ]
Cihlar, T [1 ]
Rhodes, GR [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L54 / L55
页数：2
相关论文
共 50 条
  • [41] Transcriptional upregulation of multidrug resistance-associated protein 4 (MRP4) by Nrf2 activators does not require Nrf2 participation
    Tan, Kah Poh
    Ito, Shinya
    DRUG METABOLISM REVIEWS, 2006, 38 : 251 - 252
  • [42] Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4
    El-Sheikh, Azza A. K.
    Greupink, Rick
    Wortelboer, Heleen M.
    Van den Heuvel, Jeroen J. M. W.
    Schreurs, Marieke
    Koenderink, Jan B.
    Masereeuw, Rosalinde
    Russel, Frans G. M.
    TRANSLATIONAL RESEARCH, 2013, 162 (06) : 398 - 409
  • [43] Function of the multidrug resistance protein 4 (MRP4/ABCC4) in human platelets
    Jedlitschky, G
    Lemcke, J
    Greinacher, A
    Kroemer, HK
    CIRCULATION, 2005, 112 (17) : U80 - U81
  • [44] The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
    Reid, G
    Wielinga, P
    Zelcer, N
    van der Heijden, I
    Kuil, A
    de Haas, M
    Wijnholds, J
    Borst, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) : 9244 - 9249
  • [45] The modulation of transcriptional expression and inhibition of multidrug resistance associated protein 4 (MRP4) by analgesics and their primary metabolites
    Scialis, Renato J.
    Ghanem, Carolina, I
    Manautou, Jose E.
    CURRENT RESEARCH IN TOXICOLOGY, 2020, 1 : 34 - 41
  • [46] Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP)
    Hardwick, Rhiannon N.
    Snellings, Marina
    Ferslew, Brian C.
    Lu, Yang
    Brouwer, Kim L. R.
    ADMET AND DMPK, 2016, 4 (04): : 302 - 313
  • [47] Functional analysis of multidrug resistance protein 4 (MRP4) in renal proximal tubules
    Reichel, V
    Miller, DS
    Masereeuw, R
    Fricker, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R4 - R4
  • [48] CGMP and glutathione-conjugate transport in human erythrocytes - The roles of the multidrug resistance-associated proteins, MRP1, MRP4 and MRP5
    Klokouzas, A
    Wu, CP
    van Veen, HW
    Barrand, MA
    Hladky, SB
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (18): : 3696 - 3708
  • [49] In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)
    Mailloux, Jaymie
    Medwid, Samantha
    Facey, Amanda
    Sung, Inmo
    Russell, Laura E.
    Tirona, Rommel G.
    Kim, Richard B.
    Schwarz, Ute, I
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (03): : 111 - 116
  • [50] Multiple drug resistance-associated protein 4 (MRP4) may contribute to breast cancer progression by exporting the COX-2 product PGE2
    Kochel, Tyler J.
    Reader, Jocelyn
    Kundu, Namita
    Li, Yanchun
    Ma, Xinrong
    Holt, Dawn
    Fulton, Amy
    CANCER RESEARCH, 2013, 73 (08)
12345